Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B P Roques

Showing results (411-420 of 558) with videos related to

Pageof 56
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 15, 1996
Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin releaseS Zini, M C Fournie-Zaluski, E Chauvel, et al.
Peptides|January 1, 1996
The in vivo metabolism of cholecystokinin (CCK-8) is essentially ensured by aminopeptidase AM Migaud, C Durieux, J Viereck, et al.
European Journal of Pharmacology|February 17, 1984
Different effects of mu and delta opiate agonists on respirationM P Morin-Surun, E Boudinot, G Gacel, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 1994
Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertensionM C Fournié-Zaluski, W Gonzalez, S Turcaud, et al.
Journal of Medicinal Chemistry|December 10, 1993
Synthesis and structure-activity studies of a series of [(hydroxybenzyl)amino]salicylates as inhibitors of EGF receptor-associated tyrosine kinase activityH Chen, J Boiziau, F Parker, et al.
Biopolymers|April 1, 1978
Measurement of the expected DNA lengthening caused by mono-and bisintercalating drugs using electron microscopyJ L Butour, E Delain, D Coulaud, et al.
Pharmacology, Biochemistry, and Behavior|January 1, 1991
Brain passage of BUBU, a highly selective and potent agonist for delta opioid receptors: in vivo binding and mu versus delta receptors occupancyP Delay-Goyet, M Ruiz-Gayo, A Baamonde, et al.
The Journal of Biological Chemistry|March 28, 1998
The annealing of tRNA3Lys to human immunodeficiency virus type 1 primer binding site is critically dependent on the NCp7 zinc fingers structureE Remy, H de Rocquigny, P Petitjean, et al.
Biochemical Pharmacology|June 1, 1979
DNA bifunctional intercalators: antileukemic activity of new pyridocarbazole dimersB P Roques, D Pelaprat, I Le Guen, et al.
European Journal of Pharmacology|September 3, 1998
Involvement of delta-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness modelP Tejedor-Real, J A Micó, C Smadja, et al.
Pageof 56

Showing results (411-420 of 558) with videos related to

Sort By:
Pageof 56
Proceedings of the National Academy of Sciences of the United States of America|October 15, 1996
Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin releaseS Zini, M C Fournie-Zaluski, E Chauvel, et al.
Peptides|January 1, 1996
The in vivo metabolism of cholecystokinin (CCK-8) is essentially ensured by aminopeptidase AM Migaud, C Durieux, J Viereck, et al.
European Journal of Pharmacology|February 17, 1984
Different effects of mu and delta opiate agonists on respirationM P Morin-Surun, E Boudinot, G Gacel, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 1994
Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertensionM C Fournié-Zaluski, W Gonzalez, S Turcaud, et al.
Journal of Medicinal Chemistry|December 10, 1993
Synthesis and structure-activity studies of a series of [(hydroxybenzyl)amino]salicylates as inhibitors of EGF receptor-associated tyrosine kinase activityH Chen, J Boiziau, F Parker, et al.
Biopolymers|April 1, 1978
Measurement of the expected DNA lengthening caused by mono-and bisintercalating drugs using electron microscopyJ L Butour, E Delain, D Coulaud, et al.
Pharmacology, Biochemistry, and Behavior|January 1, 1991
Brain passage of BUBU, a highly selective and potent agonist for delta opioid receptors: in vivo binding and mu versus delta receptors occupancyP Delay-Goyet, M Ruiz-Gayo, A Baamonde, et al.
The Journal of Biological Chemistry|March 28, 1998
The annealing of tRNA3Lys to human immunodeficiency virus type 1 primer binding site is critically dependent on the NCp7 zinc fingers structureE Remy, H de Rocquigny, P Petitjean, et al.
Biochemical Pharmacology|June 1, 1979
DNA bifunctional intercalators: antileukemic activity of new pyridocarbazole dimersB P Roques, D Pelaprat, I Le Guen, et al.
European Journal of Pharmacology|September 3, 1998
Involvement of delta-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness modelP Tejedor-Real, J A Micó, C Smadja, et al.
Pageof 56